Today's Date: June 3, 2023
Government of Canada releases summary of actions taken to address the safety and wellbeing of Indigenous women, girls and 2SLGBT   •   Statement by the Prime Minister to mark four years since the publication of the final report of the National Inquiry into Missin   •   LYNPARZA® (olaparib) and IMFINZI® (durvalumab) combination reduced risk of disease progression or death by 37% vs. chemo   •   San Francisco Pride Announces Headliners Hayley Kiyoko and Princess Nokia for 53rd Annual SF Pride Parade & Celebration Feat   •   Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival i   •   Exai Bio Presents New Multi-Cancer Early Detection Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting   •   56 Trilogy Health Services Communities Earn 2023 AHCA/NCAL Bronze National Quality Award   •   Bijou Ikli named new CEO by Florida Assisted Living Association   •   Air Canada's Inaugural Amsterdam-Montreal Route Takes Off; Uplifts Sustainable Aviation Fuel in Amsterdam   •   New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing   •   Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of SentinelOne, Inc. (S) on Behalf   •   High Schooler empowers Youth with Nonprofit "Unlimited Potential", raises $100,000 for Sports Medicine Research and Advocacy   •   Preliminary Ongoing Results with CYT-0851 in Combination with Capecitabine or Gemcitabine in Advanced Solid Tumors Show Early Cl   •   UNice Celebrates LGBTQ Pride Month   •   KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line   •   Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as a Single Agent After Surgery   •   Statement from Minister Hutchings on progress in support of rural Canadians   •   GRAIL Presents Real-World Experience With The Galleri® Multi-Cancer Early Detection Test At 2023 ASCO Annual Meeting   •   Promoting Diversity and Equity in Cancer Research, Women Leaders in Oncology® and Vaniam Group Announce Recipients of 2023 Y   •   Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival i
Bookmark and Share

Perfect Body Laser and Aesthetics ® Offers Tetra CoolPeel Co2 Laser Skin Resurfacing

Perfect Body Laser and Aesthetics ® Offers Tetra CoolPeel Co2 Laser Skin Resurfacing

PR Newswire

BAY SHORE, N.Y., March 24, 2023 /PRNewswire/ -- The all-new 2023 CoolPeel C02 Laser has arrived at Perfect Body Laser & Aesthetics®. Perfect Body Laser constantly seeks the very best in new laser technology to offer its 100,000+ clients.

People love the New CoolPeel C02 Laser because it can treat all skin colors, with no downtime.

The desire to find a solution like the CoolPeel C02 laser derived from a need to offer a powerful, non-invasive laser that addressed stretch marks, large pore size, hyperpigmentation, acne scarring and more.

Many people suffer from skin issues such as wrinkles, age and sunspots, sagging, freckles and fine lines. Perfect Body Laser and Aesthetics® in Bay Shore, Long Island, NY has an effective solution available for all of these problems. The CoolPeel C02 Laser was recently launched to the public and is already making huge waves. This revolutionary laser uses carbon dioxide gas to work on a variety of skin issues but is still gentle enough that it can be used on patients of all ages. The results are outstanding!

When your skin needs a facelift, Perfect Body Laser and Aesthetics® offers the most advanced CoolPeel C02 laser. The new and improved CoolPeel C02 laser is more powerful than ever with 40% faster results. The new technology delivers a treatment that is safe, effective, and comfortable. "Perfect Body Laser is the only practice in Suffolk County NY with this new technology," says Dr. Stephen Probst. "This is a game-changer for Perfect Body Laser & Aesthetics clients."

The all-new CoolPeel C02 Laser is the newest and terrific way to deliver the benefits of a traditional CO2 resurfacing treatment safely and comfortably. By targeting only the superficial layer of skin tissue, damaged skin is removed revealing younger and healthier looking skin. It combines the proven benefits of a traditional CO2 laser — removing damaged skin, improving tone and texture, enhancing collagen production for a tighter, more youthful appearance — with the added benefit of being able to treat larger areas, including stretch marks in less time.

The CoolPeel C02 laser is the first and only laser on the market to combine a cool, precise and effective carbon dioxide (CO2) laser with Tetra technology. The smooth, even energy delivered in extremely short pulses means patients can experience high levels of energy without the lingering heat that would traditionally damage the surrounding skin. The lack of unnecessary heat is why it's called "cool". And it gives an immediate aesthetic effect.

This revolutionary non-ablative CO2 laser technology has been more than ten years of groundbreaking research and development in the making. Perfect Body Laser and Aesthetics® can offer this clinically proven CoolPeel to its large client base to achieve outstanding results.

Learn more:




Press release distributed by PRLog

Cision View original content:

SOURCE Perfect Body Laser and Aesthetics

Back to top
| Back to home page

White House Live Stream
Breaking News
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News